Cargando…
The Comprehensive “Omics” Approach from Metabolomics to Advanced Omics for Development of Immune Checkpoint Inhibitors: Potential Strategies for Next Generation of Cancer Immunotherapy
In the past decade, immunotherapies have been emerging as an effective way to treat cancer. Among several categories of immunotherapies, immune checkpoint inhibitors (ICIs) are the most well-known and widely used options for cancer treatment. Although several studies continue, this treatment option...
Autores principales: | Yoon, Sang Jun, Lee, Chae Bin, Chae, Soon Uk, Jo, Seong Jun, Bae, Soo Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268114/ https://www.ncbi.nlm.nih.gov/pubmed/34203237 http://dx.doi.org/10.3390/ijms22136932 |
Ejemplares similares
-
The Transition from Cancer “omics” to “epi-omics” through Next- and Third-Generation Sequencing
por: Athanasopoulou, Konstantina, et al.
Publicado: (2022) -
Clinical Pharmacokinetics of Approved RNA Therapeutics
por: Jo, Seong Jun, et al.
Publicado: (2023) -
Analytical Method Development of Benzisothiazolinone, a Biocide, Using LC–MS/MS and a Pharmacokinetic Application in Rat Biological Matrices
por: Jo, Seong Jun, et al.
Publicado: (2023) -
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Jing, Ying, et al.
Publicado: (2020) -
The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
por: Lee, Chae Bin, et al.
Publicado: (2021)